BioCentury | Nov 30, 2018
Financial News

Feldan brings series A total to $13.8M

...Michaud said the company has three years of runway. In May 2017, Feldan partnered with Elasmogen Ltd....
...Aberdeen, U.K.) and Amgen Inc. (NASDAQ:AMGN) to use Shuttle to develop target-binding small proteins from Elasmogen...
BioCentury | Jun 15, 2017
Tools & Techniques

Breaking the barrier

...A three-way deal between Amgen Inc. , Feldan Therapeutics Inc. and Elasmogen Ltd. is the latest cause...
...a deal to combine Feldan’s intracellular delivery platform, dubbed Shuttle, with target-binding small proteins from Elasmogen...
...but also the nucleus, which CEO Francois-Thomas Michaud argues is an advantage over competitor technologies. Elasmogen’s...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Preclinical £2M ($2.5M) Reading, U.K. Immunoglobulin E (IgE) antibodies King’s College London Cancer Epidarex Capital Elasmogen Ltd....
BioCentury | May 12, 2017
Company News

Amgen developing intracellular therapies with Elasmogen, Feldan

...targeting two undisclosed intracellular targets. The companies will use Feldan's Shuttle platform in combination with Elasmogen's...
...two targets. Elasmogen was spun out of the University of Aberdeen (Aberdeen, U.K.) last year. Elasmogen Ltd....
...Inc. , Quebec, Quebec Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Business: Drug delivery, Pharmaceuticals Chris Lieu Amgen Inc. Elasmogen Ltd. Feldan...
BioCentury | May 9, 2017
Company News

Amgen developing intracellular therapies with Elasmogen, Feldan

...targeting two undisclosed intracellular targets. The companies will use Feldan's Shuttle platform in combination with Elasmogen's...
...9% of the size of an antibody, and are derived from variable new-antigen receptors (VNARS). Elasmogen...
...eye inflammatory disease. Elasmogen was spun out of the University of Aberdeen last year. Chris Lieu Amgen Inc. Elasmogen Ltd. Feldan...
BioCentury | Jul 21, 2016
Emerging Company Profile

Drugging the undruggable

...of Liverpool , University of Queensland , Wistar Institute Corporate partners: Avacta Group plc , Elasmogen Ltd....
Items per page:
1 - 6 of 6
BioCentury | Nov 30, 2018
Financial News

Feldan brings series A total to $13.8M

...Michaud said the company has three years of runway. In May 2017, Feldan partnered with Elasmogen Ltd....
...Aberdeen, U.K.) and Amgen Inc. (NASDAQ:AMGN) to use Shuttle to develop target-binding small proteins from Elasmogen...
BioCentury | Jun 15, 2017
Tools & Techniques

Breaking the barrier

...A three-way deal between Amgen Inc. , Feldan Therapeutics Inc. and Elasmogen Ltd. is the latest cause...
...a deal to combine Feldan’s intracellular delivery platform, dubbed Shuttle, with target-binding small proteins from Elasmogen...
...but also the nucleus, which CEO Francois-Thomas Michaud argues is an advantage over competitor technologies. Elasmogen’s...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Preclinical £2M ($2.5M) Reading, U.K. Immunoglobulin E (IgE) antibodies King’s College London Cancer Epidarex Capital Elasmogen Ltd....
BioCentury | May 12, 2017
Company News

Amgen developing intracellular therapies with Elasmogen, Feldan

...targeting two undisclosed intracellular targets. The companies will use Feldan's Shuttle platform in combination with Elasmogen's...
...two targets. Elasmogen was spun out of the University of Aberdeen (Aberdeen, U.K.) last year. Elasmogen Ltd....
...Inc. , Quebec, Quebec Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Business: Drug delivery, Pharmaceuticals Chris Lieu Amgen Inc. Elasmogen Ltd. Feldan...
BioCentury | May 9, 2017
Company News

Amgen developing intracellular therapies with Elasmogen, Feldan

...targeting two undisclosed intracellular targets. The companies will use Feldan's Shuttle platform in combination with Elasmogen's...
...9% of the size of an antibody, and are derived from variable new-antigen receptors (VNARS). Elasmogen...
...eye inflammatory disease. Elasmogen was spun out of the University of Aberdeen last year. Chris Lieu Amgen Inc. Elasmogen Ltd. Feldan...
BioCentury | Jul 21, 2016
Emerging Company Profile

Drugging the undruggable

...of Liverpool , University of Queensland , Wistar Institute Corporate partners: Avacta Group plc , Elasmogen Ltd....
Items per page:
1 - 6 of 6